Great. Okay. Well, first, I will say, Mac, that the Salient products include midstream energy, renewables, real estate and hedged equity with Broadmark in San Francisco. And they are highly complementary to our U.S. Value and Multi-Asset product line. And the feedback we have received so far has been very positive. We think that we can help them immediately in the institutional area, particularly in the midstream product area. They are one of the survivors that has a good long-term track record in a space that is increasingly getting flows. After a couple of rough years, it started to turn the other way with the realization that energy is 4% or 5% of the S&P now, whereas historically, it’s been more than double that. So, people are beginning to take a look and look at the long life return potential for the asset class. In the intermediary channel, we feel like expanding the team is going to help us in both the RIA and the broker-dealer channels. Salient has a really good footprint in the broker-dealer area, and we have a really strong presence in the RIA area. And I think putting the two together will really allow us to further attack the market. And to answer your second question, while we can’t do anything about the stock and bond market decline, which hit all asset managers, our core business performed relatively well from a flow perspective and exceptionally well from a client retention perspective. We have not lost a single institutional client this year, and our client retention rate in the wealth business is 96%. We had some unusual non-operating expenses this quarter, as many of you saw, with BlackRock and some of the other asset managers that have reported recently. The total non-operating expense losses for us were $1.656 million, which consisted of $731,000 of deal expenses, seed money and deferred bonus pool mark-to-market write-downs of $623,000 and a fair value adjustment to our investment in Westwood Private Bank of $302,000. So, absent all of these non-operating expenses, we would have posted a much better quarter. And in the meantime, we continue to prune expenses, buyback stock and prepare for the highly accretive integration of Salient and their subsidiary, Broadmark. And as mentioned previously, Salient is a $30 million-plus run rate revenue business. And we modeled it at industry average margins of 25% to 35%, which would be $7.5 million to $10.5 million in earnings to the bottom line. So, nothing we have seen thus far in our due diligence has changed our view, but we have got more work to do towards closing.